WHAT IS ORCHID?
Orchid overview
Orchid provides whole genome embryo screening that combines Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic/Single Gene Defects (PGT-M), and screens for hundreds of genes linked to severe monogenic diseases.
Orchid helps families maximize their chance for a successful pregnancy and healthy baby by screening embryos using whole genome sequencing.
Orchid helps families maximize their chance for a successful pregnancy and healthy baby by screening embryos using whole genome sequencing.
* Percentage is based on validation studies using genomic regions of National Institute of Standards and Technology - GIAB samples
How it works
Get the most extensive reports for your embryos

Sequencing
Your IVF doctor orders Orchid on your behalf. An embryologist sends Orchid’s lab ~5 cells from each embryo, the same amount of material required for standard testing.

Reporting
Our team of experts reviews the genetic data and reports on the information requested for each embryo in your cycle.

Expert review
Meet with a board certified genetic counselor to explain the findings from the report, discuss specific risks related to each embryo tested, and answer any questions.
Ready to get started? Speak with a board certified genetic counselor.
Get accessGet whole genome embryo screening
Make an informed decision with more data
FAQs
What genetic variations are included in Orchid’s
report?
report?
While there can be hundreds of genetic variations within an embryo, Orchid only reports on genes known to cause monogenic disease based on decades of research. Genes included on our panels are selected based on extensive literature searches and information from the Clinical Domain Working Group, a group of independent academic geneticists. Only pathogenic and likely pathogenic variants based on the American College of Medical Genetics and Genomics (ACMG) guidelines are included. Carrier status is not reported unless requested.
Who would benefit most from Orchid?
Any patient could benefit from Orchid, but a few examples of patients that would be most interest/benefit:
- Patients looking to use the most advanced genetic testing option available, or are otherwise concerned about neurodevelopmental disorders, pediatric cancers, and/or birth defects
- Patients who might traditionally do PGT-M (Orchid does not usually require probe development, which increases speed to results)
- Patients concerned about de novo variants (i.e., advanced paternal age, a previous child with a de novo variant)
- Patients using donor egg/sperm/embryos, with potentially limited contact with donor for testing
How much does Orchid cost?
Orchid’s standard Preimplantation Whole-Genome Sequencing costs roughly $12,500 for an IVF cycle with 5 biopsied embryos. However, costs may vary depending on the clinic and the complexity of a case (additional testing may incur additional costs). For cost-sensitive patients, options for more limited screening may be available. For more details please contact genetics@orchidhealth.com.